Transmitted HIV drug resistance occurs when a person acquires HIV that already contains genetic changes making the virus less responsive to certain antiretroviral medicines. These changes can affect treatment choices and influence how effectively therapy controls viral replication. Understanding transmitted drug resistance is important for HIV testing, treatment planning, and public health prevention efforts. Resistance testing can help healthcare professionals identify relevant mutations and select appropriate medication combinations. Consistent treatment, routine viral load monitoring,
HIV treatment has advanced considerably through the development of antiretroviral therapy (ART), which helps control viral replication and supports long-term health. However, transmitted drug resistance remains an important consideration in HIV care. It occurs when HIV is transmitted from one person to another with resistance-associated mutations already present in the virus. Understanding how resistance develops, how it is detected, and how it can be addressed helps explain the importance of appropriate treatment and prevention strategies.
Transmitted HIV drug resistance occurs when an individual acquires a strain of HIV that has genetic mutations associated with reduced susceptibility to one or more antiretroviral medicines. These mutations may develop in a person whose treatment has not adequately suppressed the virus and can subsequently be passed to another person.
Drug resistance does not mean that all HIV medicines will be ineffective. Its impact depends on the specific mutations and the medication classes affected. Healthcare professionals use clinical information and laboratory results to guide treatment decisions.
Important factors associated with transmitted HIV drug resistance include:
Resistance associated mutations: Changes in HIV's genetic material can reduce the effectiveness of particular antiretroviral drugs.
Previous treatment exposure in the transmitting person: Inadequate viral suppression during treatment may contribute to the selection of resistant viral strains.
Transmission of resistant strains: A person can acquire resistant HIV even without previously taking HIV medication.
Resistance testing: Genotypic testing examines viral genetic material to identify mutations that may influence treatment selection.
Treatment planning: Clinicians consider resistance results, medical history, and other relevant factors when selecting an appropriate ART regimen.
Testing recommendations may differ depending on the clinical situation, previous treatment history, and local guidelines. Resistance testing is particularly important when evaluating newly diagnosed HIV and suspected treatment failure.
Preventing the spread of resistant HIV involves effective treatment, appropriate prevention measures, and access to healthcare services. People living with HIV benefit from taking prescribed ART consistently and attending recommended follow-up appointments. Effective treatment can suppress HIV to undetectable levels, helping protect health and preventing sexual transmission when viral suppression is sustained. This principle is commonly described as Undetectable Equals Untransmittable, or U=U.
Important prevention and management approaches include:
Consistent antiretroviral therapy: Taking medication as prescribed helps maintain viral suppression and reduces the risk of resistance developing during treatment.
Routine viral load monitoring: Blood tests measure the amount of HIV in the blood and help healthcare professionals assess treatment effectiveness.
Appropriate resistance testing: Laboratory results can guide the selection of medicines when resistance is suspected or identified.
HIV prevention services: Condoms, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP), when appropriate, can help prevent HIV acquisition.
Regular clinical follow-up: Healthcare professionals can review side effects, medication interactions, adherence difficulties, and changes in viral load.
Access to accurate information: HIV education and accessible testing services support informed decisions and timely medical care.
If viral load increases despite treatment, healthcare professionals may investigate adherence challenges, medication interactions, treatment interruptions, and possible resistance before recommending changes. Medication should not be stopped or changed without professional guidance.
Understanding transmitted HIV drug resistance helps explain why resistance testing, effective treatment, and prevention services are important components of HIV care. Although resistant strains can complicate medication selection, many people can achieve viral suppression with an appropriate treatment regimen. Continued research, routine monitoring, and access to evidence-based healthcare remain essential for addressing drug resistance and improving outcomes for people living with HIV.